APA (7th ed.) Citation

Hennerici, M. G., Bots, M. L., Ford, I., Laurent, S., & Touboul, P. J. (2010). Rationale, design and population baseline characteristics of the PERFORM Vascular Project: An ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) trial. Cardiovascular drugs and therapy, 24(2), . https://doi.org/10.1007/s10557-010-6231-2

Chicago Style (17th ed.) Citation

Hennerici, Michael G., Michiel L. Bots, Ian Ford, Stéphane Laurent, and Pierre Jean Touboul. "Rationale, Design and Population Baseline Characteristics of the PERFORM Vascular Project: An Ancillary Study of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with TeRutroban in Patients with a History OF Ischemic StrOke or TRansient IscheMic Attack (PERFORM) Trial." Cardiovascular Drugs and Therapy 24, no. 2 (2010). https://doi.org/10.1007/s10557-010-6231-2.

MLA (9th ed.) Citation

Hennerici, Michael G., et al. "Rationale, Design and Population Baseline Characteristics of the PERFORM Vascular Project: An Ancillary Study of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with TeRutroban in Patients with a History OF Ischemic StrOke or TRansient IscheMic Attack (PERFORM) Trial." Cardiovascular Drugs and Therapy, vol. 24, no. 2, 2010, https://doi.org/10.1007/s10557-010-6231-2.